Aptose Bioscns (APTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Sales | 1 | 2 | 1 | 2 | 432 |
| Cost of Goods | 1 | 0 | N/A | 1 | 20 |
| Gross Profit | 0 | 2 | 1 | 1 | 420 |
| Operating Expenses | 4,841 | 4,790 | 0 | 6,431 | 5,290 |
| Operating Income | -4,840 | -4,788 | 1 | -6,429 | -4,858 |
| Interest Expense | 30 | 0 | 0 | 0 | 0 |
| Other Income | 90 | 98 | 0 | 219 | 238 |
| Pre-tax Income | -4,780 | -4,690 | 1 | -6,210 | -4,620 |
| Net Income Continuous | -4,706 | -4,721 | -5,916 | 6,217 | -4,504 |
| Net Income | $-4,706 | $-4,721 | $-5,916 | $6,217 | $-4,504 |
| EPS Basic Total Ops | -108.10 | -162.14 | -201.57 | 216.19 | -162.14 |
| EPS Basic Continuous Ops | -147.99 | -148.46 | -201.91 | 195.50 | -142.08 |
| EPS Diluted Total Ops | -108.10 | -162.14 | -201.57 | 216.19 | -162.14 |
| EPS Diluted Continuous Ops | -147.99 | -148.46 | -201.91 | 195.50 | -142.08 |
| EBITDA(a) | $-4,280 | $-5,998 | $1,201 | $-6,019 | $-4,828 |